PetMed Express Announces Board and Executive Changes

Ticker: PETS · Form: 8-K · Filed: 2025-09-12T00:00:00.000Z

Sentiment: neutral

Topics: management-change, compensation, governance

Related Tickers: PETS

TL;DR

PETS board shakeup and exec comp changes filed.

AI Summary

PetMed Express, Inc. announced on September 8, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory plans for key executives.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation can introduce uncertainty about future strategic direction and operational stability.

Key Numbers

Key Players & Entities

FAQ

Who are the specific officers or directors that have departed from PetMed Express?

The filing indicates the departure of certain officers and directors but does not name them specifically in the provided text.

What are the key details of the new compensatory arrangements for certain officers?

The filing mentions updates to compensatory arrangements but does not provide specific details on the nature or terms of these arrangements in the provided text.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on September 8, 2025.

What is the principal executive office address for PetMed Express?

The principal executive offices are located at 420 South Congress Avenue, Delray Beach, Florida 33445.

What is the SIC code for PetMed Express?

The Standard Industrial Classification (SIC) code for PetMed Express is 5912, which corresponds to Retail - Drug Stores and Proprietary Stores.

From the Filing

0001040130-25-000059.txt : 20250912 0001040130-25-000059.hdr.sgml : 20250912 20250912162008 ACCESSION NUMBER: 0001040130-25-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250908 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250912 DATE AS OF CHANGE: 20250912 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251311744 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20250908.htm 8-K pets-20250908 0001040130 FALSE 0001040130 2025-09-08 2025-09-08 0001040130 us-gaap:CommonStockMember 2025-09-08 2025-09-08 0001040130 us-gaap:PreferredStockMember 2025-09-08 2025-09-08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  September 8, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 8, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”) approved an initial annual base salary of $550,000 for Leslie C.G. Campbell, who began serving as the Company’s Interim Chief Executive Officer and President on August 11, 2025. Ms. Campbell’s initial annual base salary will be paid for the period beginning on August 11, 2025, and continuing through such time as the Board and Ms. Campbell enter into a formal

View on Read The Filing